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Biomedical researchers use of inhalational anesthetics has increased in recent years. Use of
isoflurane as an inhalational anesthetic may result in human exposure to waste anesthetic gas. Potential
health effects from exposure include genotoxic and hepatotoxic effects with some evidence of teratogenic
and reproductive effects. Research suggests that exposure to waste anesthetic gas within human hospital
settings has improved substantially but exposures to biomedical researchers and veterinarians still
requires improvement. A number of biomedical research facilities are located at The University of
Queensland, Australia, where researchers and animal handlers are potentially exposed to waste isoflurane
gas. There is limited published data on the exposures received by biomedical researchers performing
routine procedures. This project aimed to assess isoflurane exposure received during routine rodent
anesthetic protocols performed at the university. Atmospheric concentrations of isoflurane were assessed
via two methods – personal active gas sampling using sorbent tubes, and direct readings using infrared
spectroscopy. Total procedure and isoflurane exposure times ranged from 135 minutes to 268 minutes.
Personal sorbent tube sampling detected isoflurane levels from below detectable limits (<0.01░ppm) to a
Time Weighted Average for the task (TWA-Task) of 6.20░ppm (0.73 ± 9.13). Participants were not
exposed to isoflurane outside of the sampling period during the remainder of the workday. TWA-8░hr
adjusted levels ranged from below the limit of detection to 1.76░ppm isoflurane (0.69░ppm ±
0.61░ppm). The infrared spectroscopy readings taken in the breathing zone of participants ranged from
0.1░ppm to 68░ppm. Results indicate that if adequately controlled through good room ventilation,
effective active gas scavenging and well constructed anesthetic equipment, waste anesthetic exposures are
1

minimal. However, where industry standards are not met exposures may occur, including some high peak
exposures.
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INTRODUCTION
The use of isoflurane and other inhalational anesthetics in biomedical research has increased in
recent years (1). The shift towards the use of inhalation anesthesia is likely being driven by the moral and
ethical considerations associated with the use of animals in research (2). Regardless of the increase in
inhalation anesthetic use, there is still an increased anesthetic risk to rodents due to their small size. It is
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technically difficult to intubate rodents so therefore the majority of inhalation anesthetics are delivered via
a facemask and relying on the animal breathing spontaneously (2). Along with risks to rodents, researchers
and handlers can also potentially be exposed to waste anesthetic gas (WAG) (3, 4).
Concerns over the potential for reproductive and teratogenic effects from exposure to trace levels
of WAG have been raised since 1967 when Russian epidemiologists published the results of a health
questionnaire from 300 hospital anesthetists (5). Although there is evidence for such health effects from
older style halogenated anesthetics, the human evidence for isoflurane exposure is limited. Issues with
confounding variables, retrospective study designs, and lack of quantitative measures of exposure have
affected past research (6). Older style inhalational anesthetics are metabolized by the body to a much
greater extent (e.g. halothane 20--50% and methoxyflurane 50%) (7-9). The risk of health effects from
these gases is therefore greater than for isoflurane, which has a significantly lower percentage
metabolized at 0.2% (7). Data on chronic health effects from exposure to these newer style halogenated
anesthetics is lacking and there remains contradictions in the literature (10).
Occupational Exposure Standards (OES) for isoflurane have been established based upon the
effects of the older halogenated anesthetics and are outdated. Specific isoflurane OESs differ between
countries and range from a Time Weighted Average, 8-hour (TWA-8░hr) of 2░ppm in Norway to
50░ppm in the United Kingdom. In the United States, the Occupational Safety and Health Administration
(OSHA) has not established a permissible exposure limit (PEL) for isoflurane but recommends that
exposures be kept to the lowest practical level(11). The National Institute for Occupational Safety and
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Health (NIOSH) has a recommended exposure limit (REL) of 2░ppm for any halogenated anesthetic
(without concomitant nitrous oxide) for a period of time not to exceed one hour (12). Australia does not
currently have a specific OES for isoflurane but has a standard for enflurane (TWA-8░hr 0.5░ppm) (13).
Enflurane is an isomer of isoflurane having the same molecular formulae and similar toxicity(14). It is
therefore reasonable to apply this OES in an Australian setting.
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There have been considerable improvements over time in the methods for controlling workers’
exposure to trace WAG, particularly within human hospital environments. However, the control measures
required for human surgery are not always possible within a biomedical research setting and the literature
suggests that exposure to WAG is highest within research and veterinary settings (3, 4).
A number of biomedical research facilities are located at The University of Queensland (UQ),
Australia, potentially exposing researchers and animal handlers to waste isoflurane gas. Like any
potentially hazardous chemical exposure, it is important levels are kept to as low as reasonably
practicable. This project aimed to collect data on the levels of isoflurane exposure within UQ’s laboratory
animal research facilities. Personal sorbent tube sampling combined with direct readings from infrared
spectroscopy were performed during routine research anesthetic protocols to evaluate isoflurane exposure
of researchers and laboratory animal technicians.
MATERIALS AND METHODS
Ethics Approval
Human ethics approval was granted by the UQ Ethics Committee (UQ Institutional Human
Research Approval Number: 2013001289), in conjunction with approved UQ Animal Ethics (UQ Animal
Ethics Committee Approval Number: UQBR/QBI/143/13/T).
Recruitment of study participants
Study participants were volunteers recruited from amongst the University’s research higher
degree students and laboratory animal technical staff. All participants worked within laboratory animal
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research facilities and were personally administering isoflurane inhalational anesthesia to rodents. Staff
and students potentially working with isoflurane were invited to participate in the study. Five female
research higher degree students currently using isoflurane for their research projects volunteered to be
involved.
Rodent Procedures examined
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A total of six data sets were collected from participants performing isoflurane anesthetic procedures on
laboratory rodents. One participant was monitored twice on separate occasions to investigate an issue
with the room’s ventilation system. Data sets 1 and 5 involved a non-invasive ultrasound imaging
procedure requiring 15--20 minutes of immobilization per rat. In data sets 2 and 4, data was collected
from rats undergoing minor surgical intervention with each individual procedure taking no more than ten
minutes per rat. Data sets 3 and 6 involved up to 1.5 hours per rat for major surgical intervention. The
major surgical intervention differed between data sets 3 and 6, with data set 3 involving femoral artery
cannulation, while data set 6 involved cranial osteotomy for intracranial injection. Facility set-up, control
measures and anesthetic procedures differed for each data set, refer to the Facility Set-Up and Discussion
sections for further details.
Facility Set-up
Facility type and room ventilation parameters were recorded for each workstation. Facility type
was recorded as research or laboratory. A research facility was defined as an anesthetic workstation
located within a vivarium. A laboratory was defined as a workspace provided to researchers outside a
vivarium. The number of room air changes per hour and the percentage fresh air per room air change
were recorded for each facility. Data is tabulated in Table 1. All set-ups utilized active gas scavenging
systems.
An induction chamber was used for initial anesthetic induction of rodents with the exception of
data set 4 in which rats were mask-induced. For data sets 1, 3 and 5 anesthetic inductions were performed
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in a purpose-built red tinted 6░mm acrylic-sheeting box (25  35  15░cm) with a 6.4░mm oxygen inlet
and a 22░mm scavenger outlet fitting attached to the lid. The induction chamber for data set 4 was also a
purpose-built acrylic box (cm) built with 8░mm acrylic sheeting fitted with a 6.4░mm oxygen inlet and a
22░mm scavenger outlet fitting on either sides of the container. Data set 2 utilized a modified
commercially available plastic container (22  15  11░cm) as the induction chamber. Two holes were
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made on either side of the chamber to allow for an inlet hose and outlet hose to be fitted and held in place
using adhesive tape.
Data sets 1, 3 and 5 were recorded from rats maintained on a Darvall non-rebreathing circuit and
ZDS mask (Advanced Anesthesia Specialists, Gladesville, NSW Australia). A Vetquip rodent circuit with
a size 0 mask VQ3315 (Vetquip, Castle Hill, NSW Australia) was used for data set 4 and data set 2
utilized a SDR rodent mask with 7/16 diaphragm (SDR Clinical Technology, Middle Cove, NSW
Australia).
Isoflurane gas sampling and analysis
Atmospheric concentrations of isoflurane were assessed via two methods, personal active gas
sampling (to collect time weighted average samples) using sorbent tubes, and grab sampling to collect
real-time measurements using a direct reading instrument.
The personal active gas sampling (using sorbent tubes) was completed in accordance with the
Australian Standard method, AS 2986.1:2003 Workplace air quality-Sampling and analysis of volatile
organic compounds by solvent desorption/gas chromatography and specifically validated Occupational
Safety and Health Administration (OSHA) sampling method number 103 for Enflurane, Halothane and
Isoflurane (16). Sampling was completed using SKC AirChek XR5000 sampling pumps (SKC, Inc., PA)
fitted with low flow adaptor and low flow tube holder. The two sampling pumps used were within their
12-month calibration period. The samples were collected by drawing a known volume of air through SKC
Anasorb 747 sampling tubes (Cat # 226--81░A). A flow rate of 50 +/- 4░ml/min was used for all
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personal sampling. The sampling pumps were calibrated before and after sampling using a Defender 510
Low Flow DryCaL calibrator (MesaLabs, Inc. CO). Post calibration flow rates were all within +/- 5% of
pre-sampling flow rates. Two field blanks were prepared and analyzed for each set of personal air
samples. The tube holder was clipped within the breathing zone (300░mm spherical region surrounding
the mouth and nose) of each participant so that it remained in a vertical position for the duration of
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sampling. Sampling was performed for the full duration of the rodent procedure. Data was collected from
procedures of no less than 2-hours total duration, as required by the OSHA sampling method. Sample
tubes were capped and sealed immediately following sampling and were stored in a refrigerator until
being transported on ice via express courier to the laboratory for analysis. Samples were collected during
typical, routine procedures performed over a three month period. Samples were analysed by TestSafe
Australia – Chemical Analysis Branch (WorkCover New South Wales, Australia), a laboratory accredited
with the National Association of Testing Authorities, Australia (NATA) to AS ISO/IEC 17025:2005 (17).
Sampling tubes were desorbed with CS2 and analysed via Gas Chromatography (GC) with FlameIonization Detector (FID). Isoflurane concentration, oxygen flow rate and WAG scavenging equipment
were recorded for each sampling period. General room dilution ventilation including air changes per hour
were recorded for each anesthetic location.
The MIRAN 205B Series SapphIRe-XL Infrared Spectrophotometer (Thermo Electron
Corporation, Franklin, MA) was used for grab sampling and recorded direct isoflurane levels. The
detection limit of the MIRAN is 0.5░ppm with an accuracy of +/- 10% at the 11.372 micron wavelength
and a 100░ppm high range limit.
MIRAN readings were completed in accordance with the Manufacturer’s instructions. Before and after
each data collection period, an in-field zero calibration check of the instrument was performed. The direct
isoflurane readings were recorded on a field sheet, including time of reading, location and procedure

7

details. A sampling wand attached to the MIRAN was placed in the various sampling positions and
readings recorded. The MIRAN has a response time for a single wave length of 20 seconds.
Direct readings were collected from the participant’s breathing zone and surroundings (e.g.
directly above the rodent facemask, anesthetic tubing connection points, and exhaust scavenging points)
to investigate potential sources of exposure (e.g. WAG leakage from the anesthetic system). Intermittent
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MIRAN recordings were performed depending on tasks involved with each procedure to investigate
potential peak exposures, including during rodent manipulation periods (i.e. rodent movement from the
induction chamber and placement onto a facemask). Samples were recorded as close as possible within
the breathing zone of each participant and at a similar proximity to the sorbent tube. The direct reading
time was recorded along with the peak reading.
Raw data from both the personal sorbent tube sampling and the MIRAN direct readings were
collated and tabulated. Personal sorbent tube sampling data was displayed as TWA-Task (being the time
weighted average result for the period of the rodent procedure) and also as an adjusted TWA-8░hr for
comparison with Occupational Exposure Standards, based on nil exposure outside the sampling period.
All data is presented in mean ± standard deviation (for normally distributed data) or geometric mean ±
geometric standard deviation (for log normally distributed data).
Isoflurane sorbent sampling tube results were provided by TestSafe Australia as a weight of
isoflurane detected (μg). The TWA Concentration was calculated with the formula: TWA concentration =
isoflurane mass / volume of air collected. Two field blanks were prepared and analyzed for each set of
samples. All field blanks returned no detectable levels of isoflurane.
The calculated TWA-Task concentration (mg/m3) was converted to a TWA-Task (ppm) using the
formula:
TWA-Task in ppm = (TWA-Task in mg/m3 x 24.45)/gram molecular weight of isoflurane at 1 atmosphere
(760 torr or 760░mm Hg) and at 250C.
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Based on nil exposure outside the sampling period (determined via questioning of each
participant), the TWA-Task concentration was converted to a TWA-8░hr concentration in ppm for
comparison with 8-hour occupational exposure standards. Results from the direct reading instrument
(ppm readings) and from the personal sampling (TWA-8░hr and TWA-Task) were entered into the
American Industrial Hygiene Association (AIHA) software IHSTAT v2.29, for statistical analysis.
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MIRAN results were entered into the software separately for each person and descriptive statistics
calculated. All sets of MIRAN direct reading instrument results and the TWA-Task results were log
normally distributed, so non-parametric statistics were examined (geometric mean ± geometric standard
deviation). The 8-hour adjusted personal sampling results (TWA-8░hr) were normally distributed,
therefore parametric descriptive statistics were calculated (mean ± standard deviation).
RESULTS
Procedure times (isoflurane exposure) ranged from 135 minutes to 268 minutes. Personal sorbent
tube sampling detected isoflurane levels from below detectable limits to a TWA-Task of 6.20░ppm (0.73
± 9.13) (Table 1). Participants were not exposed to isoflurane outside of the sampling period during the
remainder of the workday. Adjusted TWA-8░hr levels ranged from not detectable, to 1.76░ppm
isoflurane (0.69░ppm ± 0.61░ppm) (Table 1). Direct reading MIRAN results collected from within the
breathing zone are summarized in Table 2 and are presented graphically in Figures 1 to 6. The geometric
mean ± geometric standard deviation for the MIRAN direct reading results obtained from the six
participants ranged from 0.6░ppm ± 1.5░ppm (data set 4) to 6.8░ppm ± 1.3░ppm (data set 6). Peaks
observed in the MIRAN direct readings mainly correspond with opening of the induction chamber to
place or remove the rodent (refer data sets and Figures 1, 2, 3, and 5). Higher MIRAN direct reading
results were also observed during performance of procedures requiring the researcher to work with their
head in close proximity to the rodent facemask (refer data sets and Figures 2 and 6).
DISCUSSION

9

The aim of the research was to carry out an evaluation of exposures to waste isoflurane gas
received during animal research procedures within the university’s facilities. Although the literature on
human health effects from chronic exposure to specifically isoflurane is limited, there is still a potential
health risk posed by long-term exposure to low levels of the gas. Thus, it was important to investigate
exposures and to assess the potential risk by comparing levels observed with occupational exposure
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standards. Of the six personal samples, three resulted in TWA-8░hr exposures that were higher than the
Australian OES for enflurane of 0.5░ppm but all were below isoflurane-specific international OESs for
isoflurane, which range from 2░ppm to 50░ppm (2░ppm in Norway (18), 10░ppm in Finland and Sweden
(19, 20)

and 50░ppm in Spain, Ireland and the United Kingdom (21-23)).
The concentrations found are comparable to published data. A recent study carried out in the

United States (24) reported a mean TWA-8░hr of 0.62 ± 0.47░ppm (range 0.04 – 1.64░ppm) for
pharmaceutical laboratories, which closely aligns with the mean TWA-8░hr of 0.69░ppm ± 0.61░ppm
(range <0.01 – 1.76░ppm) for biomedical facilities in this study. The MIRAN direct reading levels also
compare with other published data (3, 4, 25, 26).
The study identified a number of work practices and environmental workplace conditions that
contributed to incidences of peak exposures.
 Peak isoflurane levels were observed during anaesthetic induction and in particular during rodent
manipulation (i.e. when induction chambers were opened to remove the anaesthetised rodent and
place onto the facemask).
 Poorly fitted rodent facemasks permitted leakage of waste gas into the room atmosphere and often
directly into the breathing zone of the researcher. In data set 2, a poorly fitted rodent facemask was
used and in addition, the researcher’s breathing zone was in close proximity to the mask during each
procedure (average 8--10 minutes per rat for 10 rats). In data set 6, a latex glove was retrofitted into
a seal for the facemask, which leaked gas into the breathing zone.

10

 Higher levels of WAG were recorded due to issues with the room general dilution ventilation
system. In data sets 1 and 3, blocked air filters were found within the surgery room’s air handling
unit.
 The placement of local exhaust ventilation hoods (LEV hood) contributed to the overall WAG
exposure. In several cases the LEV hood opening was not well positioned to assist with drawing
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WAG away from the breathing zone (data sets 1, 3, 5 and 6). In comparison, data set 4 utilised a
wall mounted exhaust hood, which effectively drew WAG away from the breathing zone. In
addition, the anaesthetic scavenging hose was positioned inside the extraction hood to produce an
active anaesthetic scavenging system. These two systems in combination produced a non-detectable
level of isoflurane for data set 4.
 Custom induction chambers leaked WAG. Poor seals in custom chambers were the likely cause of
the WAG leakage into the room atmosphere from data sets 2 and 6.
RECOMMENDATIONS
Based on these observations, on recommended practices and on the results obtained from both the
personal and MIRAN direct reading results, several key control measures are recommended to reduce
WAG exposure to as low as reasonably achievable. These include:
 Use of active gas scavenging systems
 Use of commercially constructed induction chambers with good seals and correct positioning of
chambers under a LEV system designed to capture fugitive emissions and reduce peak exposures
when opening
 Use of well-designed and correctly positioned local exhaust ventilation (LEV) hoods
 Sufficient numbers of air changes per hour of 100% fresh air (27 air changes per hour was
associated with non-detectable exposure levels)
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 Ensuring rodent facemasks provide a good seal around the rodent’s face and neck and/ or ensure
adequate capture from active gas scavenging systems (e.g. LEV)
 Documented systems to ensure air filters within air handling units are well maintained
 Safe work procedures combined with training in the safe use of isoflurane.
Gas Scavenging
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Since the early reports in the 1960░s (5) and 1970░s (27-29) of the potential for inhalational
anaesthetics to cause reproductive and teratogenic effects, government bodies, particularly NIOSH (30) and
OSHA (11) in the USA, have provided guidance on the control of anaesthetic gases in human operating
theatres. The key control measure has been the use of either an active or passive gas scavenging system
on the anaesthetic machine. One study showed that commercially available charcoal canisters used for
passive scavenging in animal procedures, produced significant variations in isoflurane emissions from the
activated charcoal canisters, with some canisters emitting isoflurane levels exceeding the American 1hour ceiling concentration of 2░ppm as recommended by NIOSH (31). The study recommended the use of
passive WAG scavenging in conjunction with an active scavenging system.
Since the introduction of scavenging systems there has been no published epidemiological data
demonstrating adverse effects on operating room personnel where scavenging systems are in place (32). It
is therefore vital that scavenging systems, particularly active systems, continue to be used at the
University and other animal research facilities. It is also important that these systems be well maintained.
Active gas scavenging and local exhaust ventilation (LEV)
Findings from this study illustrate that it is possible to reduce WAG exposures to below the limits
of detection when good ventilation is in place, including the use of active gas scavenging techniques such
as LEV. The location of the LEV hood or opening is important to ensure that WAG is being drawn from
the source toward the hood and away from the breathing zone of the researcher. Induction chambers
should also be positioned under a LEV system designed to capture fugitive emissions and reduce peak
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exposures when opening. Recent published research has shown the importance of active gas scavenging
using a LEV system with a reduction in WAG levels by a maximum of 96% and mean of 85% when LEV
was used in comparison to passive gas scavenging alone (33). It is recommended that LEV systems be used
to control WAG exposures within University research facilities. Maintenance and testing of these systems
is also vital to ensure their ongoing effectiveness.
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General Room Ventilation
General room ventilation is important to remove any waste isoflurane gas present in the
atmosphere of the room. The American Institute of Architects released guidelines in 1992 for hospitals
and medical facilities, which established recommendations for room ventilation in operating rooms of 15
to 21 air exchanges per hour, of which three must be fresh outside air and in post anaesthesia rooms, six
air exchanges per hour, two of which must be fresh outdoor air (30). In Australia, air exchange rates for
health care settings, including operating rooms are established within AS 1668.2-2012: The use of
ventilation and air-conditioning in buildings, Part 2: Mechanical ventilation in buildings (34). The
Standard requires an air exchange rate of 20 air changes per hour in operating rooms and the minimum
outdoor airflow rate of, which ever is the greatest of 20░L/s per person at an occupancy of 5m2 per
person, or 10 air changes per hour of fresh air. Supply air must be filtered using high efficiency
particulate air (HEPA) filters in accordance with AS 4260:1997 High efficiency particulate air (HEPA) –
Classification, construction and performance (35).
In Australia, general requirements for the provision of adequate room ventilation for laboratories
is provided in AS/NZS 2243.1:2005: Safety in laboratories – Planning and operational aspects (36). There
are also specific requirements for ventilation of laboratories with animal containment facilities in AS/NZS
2243.3:2010 Safety in laboratories, Part 3 Microbiological safety and containment (37), which are
designed to control microbiological hazards. These requirements are specific to the levels of protection
required for biosafety purposes. In the case of data set 4 (non-detectable levels), the room ventilation
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provided was excellent (27 air changes/hour of 100% fresh air) and assisted to minimise levels to below
limits of detection and therefore below the OES, providing an excellent level of control.
Rodent facemasks
The degree to which a tight fit can be achieved between a rodent’s face and the facemask
delivering anaesthetic gas is an important factor in reducing levels of WAG in the atmosphere of the
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operating room or laboratory. In this study, when the fit did not provide a tight seal, isoflurane levels
measured in the breathing zone ranged from 5░ppm to 8.1░ppm (data set 6). When a tight seal was
achieved, the levels were much lower at approximately 0.3░ppm. A similar finding was observed in a
published study investigating the seal of rodent facemasks and the effects on isoflurane levels (38). The
authors concluded that their data suggests –
“that researchers working with standard rodent non-rebreathing circuits equipped with
conventional conical facemasks will be regularly exposed to waste isoflurane flowing through the
face/port interface. Transient contact will likely occur at levels exceeding 50░ppm …” (38).
It is recommended that isoflurane users investigate the best type of facemask to provide a tight seal
between the face and delivery system and to accommodate the needs of the procedure and disinfection
requirements.
CONCLUSION
Findings from this study indicate that the levels of exposure to WAG experienced during
experimental rodent procedures within this University setting, are low but typically, and not unexpected,
peaks occur during rodent manipulation such as opening and removal from induction chambers. It is
recommended that induction chambers be located under correctly positioned local exhaust ventilation.
Results from data set 4 illustrate that where laboratory practices are at industry standards,
including the use of effective active gas scavenging systems, it is possible to reduce waste isoflurane gas
levels to below the limits of detection and consequently below occupational exposure standards. Action is
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required to ensure that all exposures are reduced to as low as reasonably practicable by adopting the
recommended control measures consistently across all University facilities. Documented procedures
combined with training for users is required to ensure that WAG exposures are being managed in
accordance with best practice throughout the University.
Further research is required to provide more definitive information on the potential for adverse
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health effects from chronic exposure to waste anaesthetic gases such as those observed in this study. In
particular, prospective epidemiological research is required on occupationally exposed groups.
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TABLE 1. Isoflurane personal sorbent tube sampling results

Data
Set
No.

Facility
type

Animal

Room Air
Changes/
hr

% Fresh
Room Air/
Change

Induction
Type

Sample
Time (T)
(mins)

1

Research

Rats

20a

100%

Chamber

2

Laboratory

Rats

14

20%

Rats

a

100%

3

Research

Rats

5

Research

Rodents

6

Laboratory

Rats
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4

a

Research

20

27

268

Isoflurane
TWATask
(ppm)
1.77

Isoflurane
TWA8░hr
(ppm)
0.99

Chamber

135

1.45

0.41

Chamber

260

0.78

0.42
b

<0.01b

100%

Facemask

224

<0.01

20

100%

Chamber

216

1.17

0.53

unknown

unknown

Chamber

136

6.20

1.76

Blocked filters in air conditioning system at time of sampling
ND: Not Detected – limit of detection 0.01░ppm

b
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TABLE 2. Summary of MIRAN direct readings combined with personal sampling results
Personal Sorbent Tube
MIRAN Direct Reading Results Collected in Breathing Zone
Sampling Results
Data
Number of
Range
Geometric
Geometric
Isoflurane
Isoflurane
Set No. Readings in
(ppm)
Mean (ppm)
Standard
TWA-Task TWA-8░hr
Breathing
Deviation
(ppm)
(ppm)
a
Zone
(ppm)
1
27
0.8 – 66.9
4.5
3.6
1.77
0.99
2
44
4 – 68.0
14
2.0
1.45
0.41
3
31
0.1 – 54.0
2.5
4.7
0.78
0.42
b
4
8
0.3 – 1.0
0.6
1.5
<0.01
<0.01b
5
13
0.7 – 29.9
3.4
3.2
1.17
0.53
6
12
3.8 – 11.5
6.8
1.3
6.20
1.76
a
Number of direct reading samples taken in breathing zone depended in duration of procedure and
tasks undertaken during procedure
b
ND: Not Detected – limit of detection 0.01░ppm
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Activity performed by study participant

FIGURE 1. Data Set 1 – WAG MIRAN Direct Reading Results (ppm) and Activity Performed
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FIGURE 2. Data Set 2 – WAG MIRAN Direct Reading Results (ppm) and Activity Performed

24

Induction
Induction
Opening chamber
Opening chamber
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Induction
Induction
Opening chamber
Performing procedure
Performing procedure
Performing procedure
Opening chamber
Induction
Opening chamber
Opening chamber
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure
Performing procedure

WAG concentration (ppm)

Downloaded by [University of Wollongong] at 18:13 29 November 2017

Date Set 3 - WAG MIRAN Direct Reading Results (ppm) and Activity
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FIGURE 3. Data Set 3 – WAG MIRAN Direct Reading Results (ppm) and Activity Performed
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Date Set 4 - WAG MIRAN Direct Reading Results (ppm) and Activity
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FIGURE 4. Data Set 4 – WAG MIRAN Direct Reading Results (ppm) and Activity Performed
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Date Set 5 - WAG MIRAN Direct Reading Results (ppm) and Activity
Performed
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FIGURE 5. Data Set 5 – WAG MIRAN Direct Reading Results (ppm) and Activity Performed
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FIGURE 6. Data Set 6 – WAG MIRAN Direct Reading Results (ppm) and Activity Performed
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